Immune status of children with complications of BCG/BCG-M vaccination
https://doi.org/10.21292/2075-1230-2020-98-1-27-34
Abstract
The objective of the study: to analyze certain parameters of immune status in children with complications after BCG/BCG-M vaccination.
Subjects and methods. The immune status parameters were tested in 24 children who developed complications after TB vaccination such as BCG-ostitis, BCG-lymphadenitis. Lymphocyte population was assessed using flow cytofluorometry by Cytomics FC 500 (Bekman Coulter).
The serum level of immunoglobulins IgG, IgA, IgM was tested by immunodiffusion in Mancini agar. The leukocyte phagocytic activity was tested using flow cytofluorometry (Cytofluorimeter Cytomics FC 500) with FITC-labeled staphylococcus.
Results. Of the 24 children with BCG lymphadenitis or BCG ostitis, 22 (92%; 95% CI 73-99%) had abnormality in immune status.
Of the 24 children, 7 had low CD3+ count, while 9 had an elevated level of CD3+ . The level of СD4+ was low in 4 children and elevated in 15 pediatric patients. CD8+ count was low in 21 children (88%; 95% CI 72-97%). 11 children had low СD16+ number, and it was elevated in 2 children. In 10 children, low level of СD16+ was combined with low level of CD8+ . 10 children had low СD19+ number, and it was elevated in 4 children. The leukocyte phagocytic index drastically decreased (down to 37%) only in 1 child, and in 23 children, it varied from 60 to 90%.
IgG level was low in 13 (54%), and elevated in 2 (8%) children. IgA level was low in 6 (25%), and it was not detected at all in 8 (33.3%) children. IgM level was elevated in 4/24 (17%) children, while it was low in 1/24 (4%). In 8 children with no IgA detected, the IgG level was low in 5 of them, 3 had a normal level, and IgM level was elevated in 2 children, 6 children had a normal level of IgM. With IgA completely absent, 1 child had the normal level of IgG and IgM.
About the Authors
T. A. Sevostyanova
Moscow Municipal Scientific Practical Center of Tuberculosis Control
Russian Federation
Russian Federation
Tatiana A. Sevostyanova – Doctor of Medical Sciences, Head of Consulting Diagnostic Department.
3, Barbolina St., Moscow, 107014
Phone: +7 (499) 268-27-41.
V. A. Аksenova
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Valentina A. Аksenova – Doctor of Medical Sciences, Professor, Academician of RANS, Head of Department of Tuberculosis in Children and Adolescents, Chief Pediatric TB Expert.
Build. 2, 4, Dostoevskiy St., Moscow, 127473
Phone: +7 (495) 681-92-36.
D. A. Kudlay
Immunology Research Institute by the Russian Federal Medical Biological Agency
Russian Federation
Russian Federation
Dmitry A. Kudlay – Doctor of Medical Sciences, Professor, Leading Researcher of Laboratory of Personalized Medicine and Molecular Immunology.
24, Kashirskoye Highway, Moscow, 115522
Phone: +7 (499) 617-10-27.
References
1. Аksyonova V.А., Mushkin А.YU., Kovalenko K.N. BCG-ostitis in children: epidemiological rates of some regions of Russia. Probl. Tub., 2007, no. 1, pp. 9-12. (In Russ.)
2. Gomes Pagola Lina. Pervichnye immunodefitsitnye sostoyaniya s preimushhestvennoy nedostatochnostyu kletochnogo immuniteta. Avtoref. diss. dokt. med. nauk. [Primary immunodeficiency with prevailing deficiency of cell immunity. Synopsis of Doct. Diss.]. Moscow, 1992.
3. Korsunskiy I.А., Prodeus А.P., Rumyantsev А.G., Gordukova M.А., Korsunskiy А.А., Kudlay D.А., Filipenko M.L., Shuster А.M. Screening of newborns for primary immunodeficiencies and risk group for immunoregulatory disorders requiring medical follow-up. Pediatriya, 2019, vol. 98, no. 3, pp. 1-6. (In Russ.)
4. Starshinova А.А., Kudlay D.А., Dovgalyuk I.F., Basantsova N.Yu., Zinchenko Yu.S., Yablonskiy P.K. The effectiveness of new methods of immunodiagnosis of tuberculosis infection in the Russian Federation. Pediatriya im. Speranskogo, 2019, vol. 98, no. 4, pp. 229-235. (In Russ.) doi: 10.24110/0031-403X-2019-98-4-229-235.
5. Ababa F. Is interferon-gamma marker right bacillus Calmette-Guerin-induced immune defenses? Clin. Exp. Immunol., 2012, vol. 169, no. 3, pp. 213-219.
6. Aronson J.D. Protective vaccination against tuberculosis with special reference to BCG vaccination. Amer. Rev. Tuberc., 1948, vol. 58, pp. 255-281.
7. Bae W., Park K.U., Song E.Y., Kim S.J., Lee Y.J., Park J.S., Cho Y.J., Yoon H.I., Yim J.J., Lee C.T., Lee J.H. Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age. PLoS One, 2016, vol. 11, no. 6, pp. e0156917. Published 2016 Jun 3. doi: 10.1371/journal.pone.0156917.
8. Bruton O.C. Agammaglobulinemia. Pediatrics, 1952, no. 9, pp. 722-728.
9. Casanova J.L. Mendelain Susceptibility to mycobacterial infection in man. Swiss Med. Wkly, 2001, no. 131, pp. 445-454.
10. Casanova J.L., Abel L. Genetic dissection of immunity to Mycobacteria: The human model. Annu. Rev. Immunol., 2002, no. 20, pp. 581-620.
11. Gonzalez B., Moreno S., Burdach R., Valenzuela M.T., Henriquez A., Ramos M.I., Sorensen R.U. Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr. Infect. Dis. J., 1989, vol. 8, no. 4, pp. 201-206.
12. Hugosson C., Harfi H. Disseminated BCG-osteomyelitis in congenital immunodeficiency. Pediatr. Radiol., 1991, no. 21, pp. 384-385.
13. Kagina B.M., Abel B., Bowmaker M., Scriba T.J., Gelderbloem S., Smit E., Erasmus M., Nene N., Walzl G., Black G., Hussey G.D., Hesseling A.C., Hanekom W.A. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine, 2009, vol. 27, no. 40, pp. 5488-5495. doi: 10.1016/j.vaccine.2009.06.103.
14. Kobayashi Y., Komazawa Y., Kobayashi M., Matsumoto T., Sakura N., Ishikawa K., Usui T. Presumed BCG infection in a boy with chronic granulomatous disease. A report of a case and a review of the literature. Clin. Pediatr. (Phila), 1984, vol. 23, no. 10, pp. 586-589.
15. Kudlay D.A., Slogotskaya L.V., Litvinov V., Ovsyankina E., Seltsovsky P., Ivanova D., Nikolenko N. New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection. Eur. Respir. J., 2012, vol. 40, no. S56, pp. 416.
16. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., Resnick I., Fasth A., Baer M., Gomez L., Sanders E.A., Tabone M.D., Plantaz D., Etzioni A.., Monafo V., Abinun M., Hammarstrom L., Abrahamsen T., Jones A., Finn A., Klemola T., DeVries E., Sanal O., Peitsch M.C., Notarangelo L.D. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr., 1997, vol. 131 (1 Pt. 1), pp. 47-54.
17. Recalcati M.P., Valtorta E., Romitti L., Giardino D., Manfredini E., Vaccari R., Larizza L., Finelli P. Characterisation of complex chromosome 18p rearrangements in two syndromic patients with immunological deficits. Eur. J. Med. Genet., 2010, vol. 53, no. 4, pp. 186-191. doi: 10.1016/j.ejmg.2010.04.002.
18. Reichenbach J., Rosenzweig S., Döffinger R., Dupuis S., Holland S.M., Casanova J.L. Mycobacterial diseases in primary immunodeficiencies. Curr. Opin. Allergy Clin. Immunol., 2001, vol. 1, no. 6, pp. 503-511.
19. Slogotskaya L.V., Litvinov V., Ovsyankina E., Seltsovsky P., Kudlay D.A. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection. Paediatr. Respir. Rev., 2013, vol. 14, no. 2, pp. 65.
20. Stýblo K., Danková D., Drápela J., Galliová J., Jezek Z., Krivánek J., Kubík A., Langerová M., Radkovský J. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia. Report for the first 4 years of the study (1961-64). Bull World Health Organ., 1967, vol. 37, no. 6, pp. 819-874.
21. Urban C., Becker H., Mutz I., Fritsch G. BCG-infection in chronic granulomatous disease. Klin. Padiatr., 1980, no. 192, pp. 13-18.
Review
For citations:
Sevostyanova T.A., Аksenova V.A., Kudlay D.A. Immune status of children with complications of BCG/BCG-M vaccination. Tuberculosis and Lung Diseases. 2020;98(1):27-34. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-1-27-34
Views:
1138
Email this article 